查詢結果分析
相關文獻
- Intradiscal Steroid Injection for Chronic Discogenic Low Back Pain
- Transforaminal Epidural Steroid Injection for Discectomy Candidates: An Outcome Study with a Minimum of Two-Year Follow-Up
- Repeated Caudal Steroid Injections Provided Satisfactory Pain Reduction in Patients with Chronic Low Back Pain
- 椎間盤原因性的下背痛與竇椎神經
- Thoracic Disc Herniation Treated by Video-Assisted Thoracoscopic Surgery: Case Report
- Acute Retinal Necrosis-Early Manifestation and Successful Treatment with Steroid and Acyclovir: Case Report
- Eosinophilic Cystitis and Ureteritis after Radical Prostatectomy: Case Report and Literature Review
- 非類固醇類消炎藥--選擇性COX-2抑制劑
- 口服Ketorolac臨床安全性評估
- 口服Ketorolac藥物動力學特色
頁籤選單縮合
題 名 | Intradiscal Steroid Injection for Chronic Discogenic Low Back Pain=用類固醇注射到椎間盤內來治療椎間盤引起的慢性下背痛 |
---|---|
作 者 | 于尚文; 楊士階; 高玉憲; 顏政佑; 杜元坤; 陳文哲; | 書刊名 | 臺灣外科醫學會雜誌 |
卷 期 | 40:5 2007.09-10[民96.09-10] |
頁 次 | 頁193-198 |
分類號 | 416.61 |
關鍵詞 | 類固醇; 椎間盤; 慢性下背痛; Intradiscal steroid injection; Chronic low back pain; Discogenic pain; |
語 文 | 英文(English) |
中文摘要 | 椎間盤引起的慢性下背痛一直不停的困擾著很多病人,作者嘗試用minimally invasive intra-discal steroid injection (IDSI)的方法來治療這些病人,並且觀察這些病患的癒後、臨床結果及其併發症。這個Prospective study總共包括65位接受IDSI的病人,這些病人在術前都因慢性下背痛苦惱了半年以上,在接受MRI檢查,確定退化的椎間盤後,注射1cc 1%的Xylocaine和1cc的Kenacort混合劑到退化的椎間盤內,完成IDSI的手術。術後1個月、3個月、6個月、12個月病患定期回診,並以Denis Pain Scale、Denis Work Scale、Roland-Morris Scale及finger-to-floor distance做追蹤紀錄至少一年以上。在65位病人中,有52位(80%)在IDSI後一個月有明顯的改善。在治療一年後,尚有47位(72%)病人仍然感覺滿意。沒有病人發生術後的併發症。IDSI是治療椎間盤引起的慢性下背痛一項簡單而且安全的方法。只要indication正確,臨床上疼痛可望改善,病人的接受度也會很高。 |
英文摘要 | Objectives: To treat patients with chronic discogenic low back pain with intradiscal steroid injections (IDSI) and observe clinical outcomes and complications. Methods: We studied 65 patients with chronic discogenic low back pain of more than 6 months' duration, who underwent IDSI. All subjects underwent magnetic resonance imaging to identify the degenerative discs, which had high-intensity zones at the posterior annulus and positive discographic examinations. We injected 1 ml of 1% xylocaine and 1 ml of 40 mg/ml triamcinolone acetonide mixture into the degenerative disc. All patients were monitored at 1, 3, 6, and 12 months postinjection. We used the Denis pain scale, Denis work scale, Roland-Morris scale, and finger-to-floor distance for clinical evaluation and all patients were monitored for at least 1 year. Results: Fifty-two patients (80%) displayed improvement 1 month after undergoing IDSI and 47 (72%) continued to feel satisfied 12 months after undergoing this procedure. No complications were encountered. Conclusion: IDSI appears to be a simple and safe treatment for chronic discogenic low back pain. Provided that the indication for IDSI is correct, clinical improvement can be expected. |
本系統中英文摘要資訊取自各篇刊載內容。